KR860005020A - 말 및 개의 인터페론의 제조방법 - Google Patents

말 및 개의 인터페론의 제조방법

Info

Publication number: KR860005020A
Authority: KR; South Korea
Prior art keywords: dog interferon; horse; producing horse; producing; dog
Prior art date: 1984-12-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

KR1019850009607A

Other languages

English (en)

Other versions

KR940010864B1 (ko

Inventor

히믈러 아돌프

하웁트만 루돌프

하우엘 노르베르트

아돌프 귄테르

스웨틀리 피터

Original Assignee

베링거 인겔하임 인터네셔날 게엠베하

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-12-18

Filing date

1985-12-18

Publication date

1986-07-16

1985-12-18 Application filed by 베링거 인겔하임 인터네셔날 게엠베하 filed Critical 베링거 인겔하임 인터네셔날 게엠베하

1986-07-16 Publication of KR860005020A publication Critical patent/KR860005020A/ko

1994-11-18 Application granted granted Critical

1994-11-18 Publication of KR940010864B1 publication Critical patent/KR940010864B1/ko

2005-12-18 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Immunology (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Gastroenterology & Hepatology (AREA)
Biotechnology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Physics & Mathematics (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Oncology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Plant Substances (AREA)

KR1019850009607A 1984-12-18 1985-12-18 말 및 개의 인터페론의 제조방법 Expired - Fee Related KR940010864B1 (ko)

Applications Claiming Priority (8)

Application Number	Priority Date	Filing Date	Title
DEP3446124.8		1984-12-18
DEP3446122.1		1984-12-18
DE3446124		1984-12-18
DE3446122		1984-12-18
DE3529262		1985-08-16
DEP3529262.8		1985-08-16
DEP3535115.2		1985-10-02
DE3535115		1985-10-02

Publications (2)

Publication Number	Publication Date
KR860005020A true KR860005020A (ko)	1986-07-16
KR940010864B1 KR940010864B1 (ko)	1994-11-18

Family

ID=27433247

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
KR1019850009607A Expired - Fee Related KR940010864B1 (ko)	1984-12-18	1985-12-18	말 및 개의 인터페론의 제조방법

Country Status (19)

Country	Link
US (2)	US5605688A (ko)
EP (1)	EP0186098B1 (ko)
JP (1)	JPH0753596A (ko)
KR (1)	KR940010864B1 (ko)
AT (1)	ATE77410T1 (ko)
AU (1)	AU604634B2 (ko)
CA (1)	CA1339954C (ko)
DE (1)	DE3544520C2 (ko)
DK (1)	DK167929B1 (ko)
ES (1)	ES8704515A1 (ko)
FI (1)	FI90990C (ko)
GR (1)	GR853062B (ko)
HU (1)	HU212836B (ko)
IE (1)	IE58685B1 (ko)
IL (1)	IL77369A (ko)
NO (1)	NO176057C (ko)
NZ (1)	NZ214602A (ko)
PT (1)	PT81691B (ko)
WO (1)	WO1986003775A1 (ko)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI90990C (fi) *	1984-12-18	1994-04-25	Boehringer Ingelheim Int	Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
DE3642096A1 (de) *	1986-12-10	1988-06-16	Boehringer Ingelheim Int	Pferde-(gamma)-interferon
DE3932311A1 (de) *	1989-09-28	1991-04-11	Boehringer Ingelheim Int	Verfahren zur reinigung von beta-interferon
US6482403B1 (en)	1998-05-29	2002-11-19	Heska Corporation	Caniney IL-13 immunoregulatory proteins and uses thereof
US20020127200A1 (en)	1998-05-29	2002-09-12	Shumin Yang	Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
USRE40374E1 (en)	1998-05-29	2008-06-10	Heska Corporation	Canine IL-13 immunoregulatory proteins and uses thereof
EP1082432A2 (en)	1998-05-29	2001-03-14	Heska Corporation	Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
JP4616478B2 (ja)	1998-10-16	2011-01-19	バイオジェン・アイデック・エムエイ・インコーポレイテッド	インターフェロン−β−１ａのポリマー結合体および使用
JP4220235B2 (ja)	2000-11-03	2009-02-04	インターシアセラピューティクス，インコーポレイティド	短期及び長期の薬剤薬量決定のための方法
CA2466228A1 (en) *	2001-11-09	2003-08-07	Biomedicines, Inc.	Method for treating diseases with omega interferon
US20040072236A1 (en) *	2002-09-27	2004-04-15	Neil Cashman	PrPSc -interacting molecules and uses thereof
US7731947B2 (en)	2003-11-17	2010-06-08	Intarcia Therapeutics, Inc.	Composition and dosage form comprising an interferon particle formulation and suspending vehicle
WO2006083761A2 (en)	2005-02-03	2006-08-10	Alza Corporation	Solvent/polymer solutions as suspension vehicles
US11246913B2 (en)	2005-02-03	2022-02-15	Intarcia Therapeutics, Inc.	Suspension formulation comprising an insulinotropic peptide
KR101106510B1 (ko)	2006-05-30	2012-01-20	인타르시아 세라퓨틱스 인코포레이티드	투피스, 내부채널 삼투압 전달 시스템 유동 조절기
CN102274557B (zh)	2006-08-09	2014-12-03	精达制药公司	渗透性递送系统和活塞组件
WO2008133908A2 (en)	2007-04-23	2008-11-06	Intarcia Therapeutics, Inc.	Suspension formulations of insulinotropic peptides and uses thereof
US8343140B2 (en)	2008-02-13	2013-01-01	Intarcia Therapeutics, Inc.	Devices, formulations, and methods for delivery of multiple beneficial agents
KR101823699B1 (ko)	2009-09-28	2018-01-30	인타르시아 세라퓨틱스 인코포레이티드	실질 항정상태 약물 전달의 신속 확립 및/또는 종결
US20120208755A1 (en)	2011-02-16	2012-08-16	Intarcia Therapeutics, Inc.	Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
RS57175B1 (sr)	2011-03-15	2018-07-31	Biogen Ma Inc	Postupak za smanjenje simptoma sličnih gripu povezanih sa intramuskularnom primenom interferona korišćenjem režima brze titracije sa povećanjem doze
CN102321169A (zh) *	2011-09-30	2012-01-18	长春工业大学	一种犬重组干扰素α及制备方法
US9889085B1 (en)	2014-09-30	2018-02-13	Intarcia Therapeutics, Inc.	Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
EP3302354B1 (en)	2015-06-03	2023-10-04	i2o Therapeutics, Inc.	Implant placement systems
SG10201913699QA (en)	2016-05-16	2020-03-30	Intarcia Therapeutics Inc	Glucagon-receptor selective polypeptides and methods of use thereof
USD860451S1 (en)	2016-06-02	2019-09-17	Intarcia Therapeutics, Inc.	Implant removal tool
USD840030S1 (en)	2016-06-02	2019-02-05	Intarcia Therapeutics, Inc.	Implant placement guide
US10835580B2 (en)	2017-01-03	2020-11-17	Intarcia Therapeutics, Inc.	Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
CN108424915A (zh) *	2018-01-12	2018-08-21	中国农业科学院北京畜牧兽医研究所	犬干扰素-α2重组蛋白的制备方法
CN108486127A (zh) *	2018-01-12	2018-09-04	中国农业科学院北京畜牧兽医研究所	犬干扰素-α6α7重组蛋白及其制备方法与应用
CN111233998B (zh) *	2018-08-02	2021-10-19	中国农业科学院北京畜牧兽医研究所	一种犬干扰素CaIFN-λ突变体及其应用
GB202011945D0 (en) *	2020-07-31	2020-09-16	Ilc Therapeutics Ltd	Compositions and methods relating to the treatment of diseases
CN112079912B (zh) *	2020-09-25	2022-05-06	广州源博医药科技有限公司	一种高活性的犬α干扰素重组蛋白及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1980002375A1 (en) *	1977-09-23	1980-11-13	Hem Res Inc	High purity animal interferons
US4262090A (en) *	1979-06-04	1981-04-14	Cetus Corporation	Interferon production
ZA811368B (en) *	1980-03-24	1982-04-28	Genentech Inc	Bacterial polypedtide expression employing tryptophan promoter-operator
DE3176011D1 (en) *	1980-06-12	1987-04-23	Japan Found Cancer	Plasmid
US4436815A (en) *	1981-11-27	1984-03-13	Eli Lilly And Company	Method for stabilizing and selecting recombinant DNA containing host cells
IE54592B1 (en) *	1982-03-08	1989-12-06	Genentech Inc	Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
AR241654A1 (es) *	1982-05-05	1992-10-30	Genentech Inc	Procedimiento para producir activador de plasminogeno de tejido humano.
DE3247922A1 (de) *	1982-12-24	1984-06-28	Boehringer Ingelheim International GmbH, 6507 Ingelheim	Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
JPS60118196A (ja) *	1983-11-30	1985-06-25	Takeda Chem Ind Ltd	インタ−フェロンの製造法
US4606917A (en) *	1984-10-03	1986-08-19	Syntex (U.S.A) Inc.	Synergistic antiviral composition
FI90990C (fi) *	1984-12-18	1994-04-25	Boehringer Ingelheim Int	Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
US4689224A (en) *	1985-10-07	1987-08-25	Neogen Corporation	Method for administering vaccines containing equine leukokines and compositions therefor

1985
- 1985-12-16 FI FI854994A patent/FI90990C/fi not_active IP Right Cessation
- 1985-12-17 ES ES550043A patent/ES8704515A1/es not_active Expired
- 1985-12-17 WO PCT/EP1985/000716 patent/WO1986003775A1/de unknown
- 1985-12-17 AT AT85116083T patent/ATE77410T1/de not_active IP Right Cessation
- 1985-12-17 DK DK586585A patent/DK167929B1/da not_active IP Right Cessation
- 1985-12-17 IE IE319485A patent/IE58685B1/en not_active IP Right Cessation
- 1985-12-17 HU HU854811A patent/HU212836B/hu not_active IP Right Cessation
- 1985-12-17 IL IL77369A patent/IL77369A/xx not_active IP Right Cessation
- 1985-12-17 EP EP85116083A patent/EP0186098B1/de not_active Expired - Lifetime
- 1985-12-17 AU AU51320/85A patent/AU604634B2/en not_active Ceased
- 1985-12-17 NZ NZ214602A patent/NZ214602A/en unknown
- 1985-12-17 NO NO855078A patent/NO176057C/no unknown
- 1985-12-17 PT PT81691A patent/PT81691B/pt not_active IP Right Cessation
- 1985-12-17 DE DE3544520A patent/DE3544520C2/de not_active Expired - Fee Related
- 1985-12-18 KR KR1019850009607A patent/KR940010864B1/ko not_active Expired - Fee Related
- 1985-12-18 GR GR853062A patent/GR853062B/el unknown
- 1985-12-18 CA CA000497972A patent/CA1339954C/en not_active Expired - Fee Related
1994
- 1994-03-28 JP JP6057871A patent/JPH0753596A/ja active Pending
- 1994-09-08 US US08/302,391 patent/US5605688A/en not_active Expired - Fee Related
1997
- 1997-02-24 US US08/805,165 patent/US5798228A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
NO176057B (no)	1994-10-17
DE3544520A1 (de)	1986-12-18
DE3544520C2 (de)	1995-07-20
IE58685B1 (en)	1994-02-09
JPH0753596A (ja)	1995-02-28
FI854994A0 (fi)	1985-12-16
DK167929B1 (da)	1994-01-03
IE853194L (en)	1986-06-18
KR940010864B1 (ko)	1994-11-18
ATE77410T1 (de)	1992-07-15
AU604634B2 (en)	1991-01-03
PT81691B (pt)	1988-04-21
ES550043A0 (es)	1987-04-01
AU5132085A (en)	1986-06-26
GR853062B (ko)	1986-04-21
DK586585D0 (da)	1985-12-17
DK586585A (da)	1986-06-19
CA1339954C (en)	1998-07-14
WO1986003775A1 (en)	1986-07-03
ES8704515A1 (es)	1987-04-01
NO855078L (no)	1986-06-19
EP0186098A1 (de)	1986-07-02
IL77369A (en)	1993-07-08
EP0186098B1 (de)	1992-06-17
US5798228A (en)	1998-08-25
FI90990B (fi)	1994-01-14
FI854994L (fi)	1986-06-19
HU212836B (en)	1996-12-30
PT81691A (de)	1986-01-01
HUT40165A (en)	1986-11-28
US5605688A (en)	1997-02-25
NO176057C (no)	1995-01-25
NZ214602A (en)	1991-06-25
FI90990C (fi)	1994-04-25

Publication	Publication Date	Title
KR860005020A (ko)	1986-07-16	말 및 개의 인터페론의 제조방법
FI863378A7 (fi)	1986-08-21	Interferonin puhdistusmenetelmä.
DE3584937D1 (de)	1992-01-30	Schimmelbekaempfungsmittel.
FI875427L (fi)	1988-06-11	Menetelmä valmistaa hevosen -interferonia
BR8505703A (pt)	1986-08-12	Ferradura equina
FI90667C (fi)	1994-03-10	Menetelmä valmistaa uutta ihmisen tyypin I interferoniproteiinia
FI850827A0 (fi)	1985-02-28	Saetesutrustning foer barn i fordon.
NO873389L (no)	1988-02-15	Homogent rekombinant immun-interferon-fragment.
IT8619023A0 (it)	1986-01-08	Metodo di controllo dell'iniezione di combustibile.
FI832252A7 (fi)	1983-12-22	Parannettu menetelmä interferonin tuottamiseksi.
FI861748A7 (fi)	1986-10-28	Menetelmä -interferonin valmistamiseksi ja puhdistamiseksi.
FI852866L (fi)	1986-01-28	Rekombinantfaktor viii-r.
FI862738A7 (fi)	1986-06-26	Menetelmä ihmisleukosyyttien interferonin valmistamiseksi.
FI853177A7 (fi)	1986-02-22	Menetelmä geenien tuottamiseksi E-colissasynteettisen säätöalueen avulla.
KR880009039A (ko)	1988-09-13	재조합 α-인터페론의 정제방법
FI851037A7 (fi)	1985-09-20	Geeniteknologinen menetelmä ihmisgammainterferonin valmistamiseksi ja aineita tämän menetelmän toteuttamiseksi.
NO157968C (no)	1988-06-22	Sagbukk.
NO154890C (no)	1987-01-07	Ventilasjonshette.
FI872734A7 (fi)	1988-10-16	Ventilationsgaller foersett med ett integrerat avgasningssystem.
KR860004595A (ko)	1986-07-11	동물성 가수 단백분해물 제조방법
IT8421163V0 (it)	1984-03-08	Apparecchio sollevatore per bovini.
KR870011246A (ko)	1987-12-22	인간 β-인터페론 유전자를 지닌 대장균 유전자 운반체의 제조방법
IT8429508V0 (it)	1984-02-01	Horse car
BR6501041U (pt)	1987-03-04	Cavalete visual-a.
FI853365L (fi)	1986-03-08	Koer- och handbroms foer fordon.

Legal Events

Date	Code	Title	Description
1985-12-18	PA0109	Patent application	St.27 status event code: A-0-1-A10-A12-nap-PA0109
1985-12-18	R17-X000	Change to representative recorded	St.27 status event code: A-3-3-R10-R17-oth-X000
1986-03-18	P11-X000	Amendment of application requested	St.27 status event code: A-2-2-P10-P11-nap-X000
1986-03-18	P13-X000	Application amended	St.27 status event code: A-2-2-P10-P13-nap-X000
1986-07-16	PG1501	Laying open of application	St.27 status event code: A-1-1-Q10-Q12-nap-PG1501
1990-11-13	A201	Request for examination
1990-11-13	P11-X000	Amendment of application requested	St.27 status event code: A-2-2-P10-P11-nap-X000
1990-11-13	P13-X000	Application amended	St.27 status event code: A-2-2-P10-P13-nap-X000
1990-11-13	PA0201	Request for examination	St.27 status event code: A-1-2-D10-D11-exm-PA0201
1991-08-21	R17-X000	Change to representative recorded	St.27 status event code: A-3-3-R10-R17-oth-X000
1993-12-30	E902	Notification of reason for refusal
1993-12-30	PE0902	Notice of grounds for rejection	St.27 status event code: A-1-2-D10-D21-exm-PE0902
1994-02-26	T11-X000	Administrative time limit extension requested	St.27 status event code: U-3-3-T10-T11-oth-X000
1994-03-26	T11-X000	Administrative time limit extension requested	St.27 status event code: U-3-3-T10-T11-oth-X000
1994-04-27	T11-X000	Administrative time limit extension requested	St.27 status event code: U-3-3-T10-T11-oth-X000
1994-05-27	T11-X000	Administrative time limit extension requested	St.27 status event code: U-3-3-T10-T11-oth-X000
1994-06-28	P11-X000	Amendment of application requested	St.27 status event code: A-2-2-P10-P11-nap-X000
1994-06-28	P13-X000	Application amended	St.27 status event code: A-2-2-P10-P13-nap-X000
1994-10-24	G160	Decision to publish patent application
1994-11-18	PG1605	Publication of application before grant of patent	St.27 status event code: A-2-2-Q10-Q13-nap-PG1605
1995-01-24	E701	Decision to grant or registration of patent right
1995-01-24	PE0701	Decision of registration	St.27 status event code: A-1-2-D10-D22-exm-PE0701
1995-02-20	GRNT	Written decision to grant
1995-02-20	PR0701	Registration of establishment	St.27 status event code: A-2-4-F10-F11-exm-PR0701
1995-02-20	PR1002	Payment of registration fee	St.27 status event code: A-2-2-U10-U11-oth-PR1002 Fee payment year number: 1
1997-10-21	PR1001	Payment of annual fee	St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4
1998-10-23	FPAY	Annual fee payment	Payment date: 19981023 Year of fee payment: 5
1998-10-23	PR1001	Payment of annual fee	St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 5
1999-11-19	LAPS	Lapse due to unpaid annual fee
1999-11-19	PC1903	Unpaid annual fee	St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 19991119 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE
2000-08-08	PC1903	Unpaid annual fee	St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 19991119
2004-10-01	R18-X000	Changes to party contact information recorded	St.27 status event code: A-5-5-R10-R18-oth-X000
2007-10-18	R18-X000	Changes to party contact information recorded	St.27 status event code: A-5-5-R10-R18-oth-X000